PPA Module KMS

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/164

encourage image

There's no tags or description

Looks like no tags are added yet.

165 Terms

1
New cards

2.1 | Corpus callosum

Connects the two cerebral hemispheres and allows them to communicate.

2
New cards

2.1 | Cerebellum

Coordinates balance, posture, and movement.

3
New cards

2.1 | Thalamus

Major relay station that sends sensory information to the cerebral cortex.

4
New cards

2.1 | Hypothalamus

Regulates endocrine and autonomic/visceral functions, temperature, hunger, and homeostasis.

5
New cards

2.1 | Limbic system

Involved in emotion and memory.

6
New cards

2.1 | Frontal lobe

Important for planning, judgment, decision-making, and voluntary movement.

7
New cards

2.1 | Reception

Detection of a stimulus by a sensory receptor.

8
New cards

2.1 | Transduction

Conversion of a stimulus into an electrical signal or generator potential.

9
New cards

2.1 | Coding

Encoding stimulus information, such as intensity, through neuronal firing patterns/frequency.

10
New cards

2.1 | At what stage does perception occur?

At the coding/central processing stage, not at transduction.

11
New cards

2.2 | A-delta fibers

Fast, sharp, well-localized pain; thinly myelinated.

12
New cards

2.2 | C fibers

Slow, dull, burning pain; unmyelinated.

13
New cards

2.2 | A-beta fibers

Primarily carry non-painful touch/pressure information.

14
New cards

2.2 | Bradykinin

Inflammatory mediator that contributes strongly to pain and vasodilation.

15
New cards

2.2 | Histamine

Promotes vasodilation and especially increases vascular permeability in acute inflammation.

16
New cards

2.2 | Prostaglandins

Contribute to inflammation, vasodilation, and pain sensitization.

17
New cards

2.2 | Leukotrienes

Inflammatory mediators; promote bronchoconstriction and are important in asthma/allergic inflammation.

18
New cards

2.2 | TNF-alpha

Pro-inflammatory cytokine involved in chronic inflammation, including rheumatoid arthritis.

19
New cards

2.2 | Paresthesia

Abnormal sensation such as tingling, prickling, or pins and needles.

20
New cards

2.2 | Dysesthesia

Unpleasant abnormal sensation, often burning or painful.

21
New cards

2.2 | Hyperalgesia

Increased pain response to a stimulus that is normally painful.

22
New cards

2.2 | Allodynia

Pain caused by a stimulus that is normally not painful.

23
New cards

2.2 | Causalgia

Persistent burning pain, typically associated with nerve injury/complex regional pain syndrome.

24
New cards

2.2 | Phantom limb pain

Pain perceived in a limb or body part that has been amputated.

25
New cards

2.2 | Anesthesia dolorosa

Pain in an area that is otherwise numb, often after nerve injury.

26
New cards

2.2 | Diabetic peripheral neuropathy

Nerve damage from diabetes that can cause numbness, tingling, burning pain, or altered sensation, often in the feet.

27
New cards

2.2 | NSAIDs

Best suited for pain associated with inflammation and tissue injury.

28
New cards

2.2 | Opioids

Act on opioid receptors to reduce pain signaling; used for moderate-to-severe pain but carry respiratory-depression and dependence risks.

29
New cards

2.2 | Gabapentin and other anticonvulsants

Commonly used for neuropathic pain.

30
New cards

2.2 | TCAs (e.g., amitriptyline)

Can treat neuropathic pain by altering monoamine signaling.

31
New cards

2.2 | Local anesthetics

Block voltage-gated sodium channels to prevent action-potential conduction and sensation.

32
New cards

2.3 | NMDA receptor

Ionotropic glutamate receptor permeable to Na+ and Ca2+ (with K+ efflux); blocked by Mg2+ at resting membrane potential.

33
New cards

2.3 | What removes the Mg2+ block from NMDA?

Postsynaptic depolarization, typically produced by glutamate-driven AMPA receptor activity.

34
New cards

2.3 | Long-term potentiation (LTP)

Long-lasting strengthening of synaptic transmission; classically involves glutamate, NMDA receptor activation, and removal of the Mg2+ block.

35
New cards

2.3 | Glutaminase

Converts glutamine into glutamate.

36
New cards

2.3 | Glutamine synthetase

Converts glutamate into glutamine, mainly in glial cells.

37
New cards

2.3 | Glutamate dehydrogenase (GDH)

Converts glutamate into alpha-ketoglutarate.

38
New cards

2.3 | EAAT

Excitatory amino acid transporter; mediates glutamate reuptake into neurons and glial cells.

39
New cards

2.3 | VGLUT

Vesicular glutamate transporter; packages glutamate into synaptic vesicles.

40
New cards

2.4 | GABA synthesis

Glutamate is converted to GABA by glutamic acid decarboxylase (GAD).

41
New cards

2.4 | GAT

GABA transporter responsible for GABA reuptake into neurons and glial cells.

42
New cards

2.4 | VGAT

Vesicular GABA transporter; also transports glycine into vesicles.

43
New cards

2.4 | GABA-T

Enzyme that metabolizes GABA to glutamate-related intermediates, especially in glial cells.

44
New cards

2.4 | GABAA receptor

Ionotropic Cl− channel; produces fast inhibitory signaling, generally hyperpolarizing the postsynaptic neuron.

45
New cards

2.4 | GABAB receptor

Metabotropic Gi/o-coupled receptor; inhibits adenylyl cyclase, reduces Ca2+ entry, and increases K+ conductance to inhibit neurotransmitter release.

46
New cards

2.4 | Benzodiazepines

Positive allosteric modulators of GABAA receptors; increase the effect of GABA and promote anxiolysis/sedation.

47
New cards

2.4 | Baclofen

GABAB receptor agonist.

48
New cards

2.4 | Muscimol

GABAA receptor agonist.

49
New cards

2.5 | Dopamine synthesis

Tyrosine → L-DOPA via tyrosine hydroxylase → dopamine via DOPA decarboxylase/AADC.

50
New cards

2.5 | Rate-limiting enzyme in dopamine synthesis

Tyrosine hydroxylase.

51
New cards

2.5 | DAT

Dopamine transporter; reuptakes dopamine from the synapse into the presynaptic neuron.

52
New cards

2.5 | VMAT1/2

Vesicular monoamine transporters; package dopamine and other monoamines into vesicles.

53
New cards

2.5 | Dopamine metabolism

Primarily by MAO and COMT; metabolites include DOPAC and homovanillic acid (HVA).

54
New cards

2.5 | D1 receptors

Generally excitatory; coupled to Gs and increase cAMP.

55
New cards

2.5 | D2 receptors

Generally inhibitory; coupled to Gi and decrease cAMP.

56
New cards

2.5 | Apomorphine

D2 agonist; D2 activation in the chemoreceptor trigger zone can promote vomiting.

57
New cards

2.5 | Cocaine mechanism

Blocks DAT, reducing dopamine reuptake and increasing/prolonging dopamine in the synaptic space.

58
New cards

2.5 | A10 pathway

Mesolimbic dopamine pathway strongly associated with reward, reinforcement, and addiction.

59
New cards

2.6 | Norepinephrine synthesis

Dopamine is converted to norepinephrine by dopamine beta-hydroxylase.

60
New cards

2.6 | Epinephrine synthesis

Norepinephrine is converted to epinephrine by phenylethanolamine N-methyltransferase (PNMT).

61
New cards

2.6 | NE/EPI reuptake

Primarily by NET.

62
New cards

2.6 | NE/EPI vesicular transport

VMAT packages norepinephrine and epinephrine into vesicles.

63
New cards

2.6 | NE/EPI metabolism

MAO and COMT.

64
New cards

2.6 | NE in locus coeruleus

Supports arousal/alertness, attention, and memory-related functions.

65
New cards

2.6 | MAOI food interaction

MAOIs reduce tyramine breakdown; high tyramine intake can cause excessive catecholamine release and hypertensive crisis.

66
New cards

2.6 | Propranolol

Nonselective beta-adrenergic antagonist; blocks beta receptor signaling and reduces heart rate and blood pressure.

67
New cards

2.7 | Acetylcholine synthesis

Choline + acetyl-CoA are combined by choline acetyltransferase (ChAT) to form ACh.

68
New cards

2.7 | CHT1

High-affinity choline transporter that brings choline into the presynaptic neuron.

69
New cards

2.7 | VAChT

Vesicular acetylcholine transporter; packages ACh into synaptic vesicles.

70
New cards

2.7 | Does acetylcholine undergo reuptake?

NO. Acetylcholine is broken down in the synaptic cleft by acetylcholinesterase; choline is taken back up by CHT1 and reused.

71
New cards

2.7 | Acetylcholinesterase (AChE)

Breaks acetylcholine into choline and acetate in the synaptic cleft.

72
New cards

2.7 | nAChR

Nicotinic acetylcholine receptor; ionotropic, ligand-gated cation channel that produces fast excitation.

73
New cards

2.7 | mAChR

Muscarinic acetylcholine receptor; metabotropic GPCR with slower effects that can be excitatory or inhibitory depending on subtype.

74
New cards

2.7 | M1/M3/M5 receptors

Muscarinic receptor subtypes generally coupled to Gq and excitatory signaling.

75
New cards

2.7 | M2/M4 receptors

Muscarinic receptor subtypes generally coupled to Gi and inhibitory signaling.

76
New cards

2.7 | ACh in basal forebrain

Supports attention, learning, and information processing.

77
New cards

2.7 | ACh in brainstem (PPN/LDT)

Involved in sleep-wake regulation and motor control.

78
New cards

2.8 | Histamine synthesis

Histidine is converted to histamine by histidine decarboxylase.

79
New cards

2.8 | Histamine vesicular transport

VMAT packages histamine into vesicles in neurons.

80
New cards

2.8 | Does histamine undergo reuptake?

No; histamine signaling is primarily terminated by enzymatic metabolism.

81
New cards

2.8 | H1 receptor

Gq-coupled; associated with arousal and many allergic/inflammatory effects.

82
New cards

2.8 | H2 receptor

Gs-coupled; increases gastric acid secretion.

83
New cards

2.8 | H3 receptor

Gi/o-coupled presynaptic autoreceptor; reduces histamine release.

84
New cards

2.8 | H4 receptor

Gi/o-coupled; involved in immune and inflammatory responses.

85
New cards

2.8 | Pitolisant

H3 receptor antagonist/inverse agonist; increases histamine signaling and promotes wakefulness in narcolepsy.

86
New cards

2.8 | Why can H1 antihistamines cause drowsiness?

Blocking central H1 receptors reduces histamine-mediated arousal.

87
New cards

2.9 | Serotonin synthesis

Tryptophan → 5-HTP via tryptophan hydroxylase → serotonin via AADC.

88
New cards

2.9 | Rate-limiting enzyme in serotonin synthesis

Tryptophan hydroxylase.

89
New cards

2.9 | SERT

Serotonin transporter; reuptakes serotonin from the synapse.

90
New cards

2.9 | Fluoxetine

SSRI that inhibits SERT, reducing serotonin reuptake.

91
New cards

2.9 | Reserpine

Inhibits VMAT2, preventing monoamines such as serotonin from being packaged into vesicles.

92
New cards

2.9 | Serotonin metabolism

MAO followed by aldehyde dehydrogenase (ALDH) produces 5-HIAA.

93
New cards

2.9 | 5-HT1 autoreceptors

Presynaptic inhibitory Gi-coupled receptors that provide negative feedback and reduce serotonin firing/release.

94
New cards

2.9 | Does peripheral serotonin replenish brain serotonin?

No. Peripheral serotonin does not meaningfully cross the blood-brain barrier; the CNS synthesizes its own serotonin from tryptophan.

95
New cards

2.10 | Endorphins and opioid receptors

Endorphins preferentially bind mu (μ/MOR) receptors.

96
New cards

2.10 | Enkephalins and opioid receptors

Enkephalins preferentially bind delta (δ/DOR) receptors.

97
New cards

2.10 | Dynorphins and opioid receptors

Dynorphins preferentially bind kappa (κ/KOR) receptors.

98
New cards

2.10 | Opioid receptor signaling

MOR, DOR, and KOR are Gi/o-coupled GPCRs; inhibit adenylyl cyclase, decrease cAMP, increase K+ efflux, and decrease Ca2+ influx.

99
New cards

2.10 | How do opioids hyperpolarize neurons?

They increase K+ conductance/efflux, making the inside of the neuron more negative.

100
New cards

2.10 | How do opioids reduce neurotransmitter release?

They inhibit voltage-gated Ca2+ entry at presynaptic terminals.